J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Index
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sam, I.-C
Right arrow Articles by Smith, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sam, I.-C
Right arrow Articles by Smith, M
Agricola
Right arrow Articles by Sam, I.-C
Right arrow Articles by Smith, M
J Med Microbiol 54 (2005), 453-455; DOI: 10.1099/jmm.0.45836-0
© 2005 Society for General Microbiology
ISSN 0022-2615

Failure to detect capsule gene bexA in Haemophilus influenzae types e and f by real-time PCR due to sequence variation within probe binding sites

I.-C Sam and M Smith

Health Protection Agency London, Department of Virology, King's College Hospital (Dulwich site), Dulwich Hospital, East Dulwich Grove, London SE22 8QF, UK

Correspondence M. Smith melvyn.smith{at}kcl.ac.uk

Received July 23, 2004
Accepted January 21, 2005

Detection of the conserved capsule gene bexA is used to distinguish capsulate from non-capsulate Haemophilus influenzae. While developing a real-time PCR assay to detect bexA, it was found that bexA probes produced a detectable signal for H. influenzae types a to d, but failed to do so for H. influenzae types e and f. Sequencing revealed differences compared with H. influenzae types a to d within probe binding sites. To prevent misclassification of strains as non-capsulate, assays must detect all capsular types.


Abbreviations: HIB, H. influenzae type b; HIE, H. influenzae type e; HIF, H. influenzae type f; NC, non-capsulate.

Sequence alignment data are available as supplementary data in JMM Online.


    INTRODUCTION
 TOP
 INTRODUCTION
 METHODS
 RESULTS AND DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
Haemophilus influenzae can be typed into six capsular types (a to f) and non-typable, non-capsulate (NC) strains. The bexA gene, which is involved in exportation of capsular material, is conserved in all six capsular types (Kroll et al., 1988, 1989, 1990). Gel-based PCR detection of bexA, distinguishing capsulate from NC strains, and detection of capsule type-specific targets is the gold standard by which surveillance of trends in invasive H. influenzae types is achieved (Falla et al., 1994; Gonin et al., 2000; Slack et al., 1998).

Real-time PCR is increasingly used as an alternative to conventional PCR as it offers several advantages. It is more rapid and enables specific product confirmation, using a closed system that reduces the number of manipulations and risk of contamination.

While evaluating a real-time PCR assay for detection of bexA in H. influenzae strains, we noticed that, unlike strains of H. influenzae types a to d, H. influenzae types e (HIE) and f (HIF) failed to produce detectable signals with bexA probes. The amplicons of 12 capsulate H. influenzae strains were sequenced to investigate these findings.


    METHODS
 TOP
 INTRODUCTION
 METHODS
 RESULTS AND DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
Bacterial isolates.

The 20 cultures used to test the assay were clinical isolates, except for three strains from the National Collection of Type Cultures (Colindale, UK): H. influenzae types a (n = 1), b (n = 3, including NCTC 8467T), c (n = 2), d (n = 2), e (n = 2) and f (n = 2); capsule-deficient type b (n = 2) and NC strains (n = 2); Haemophilus aphrophilus (n = 2), Haemophilus haemolyticus (n = 1, NCTC 10659T) and Neisseria meningitidis (n = 1, NCTC 10026T). DNA was extracted from a heavy sweep using the Easy-DNA kit (Invitrogen) according to the manufacturer's instructions.

Detection of bexA by real-time PCR.

Previously published primers bexAF (5'-CGTTTGTATGATGTTGATCCAGA) and bexAR (5'-TGTCCATGTCTTCAAAATGATG-3') target a 343 bp region within the bexA gene (van Ketel et al., 1990). These were used with newly designed adjacent hybridization probes bexAabcdD (donor, 5'-GAGAAACGCAAAGACCGTTCT-fluorescein-3') and bexAabcdA (acceptor, 5'-LC Red 640-TCATTTTAGTTTCACATAGCCCG-phosphate-3'). A LightCycler (Roche Diagnostics) was used, with reaction mixtures containing 2 µl LightCycler DNA Master Hybridization Probes (Roche), 3 mM MgCl2, 10 pM each primer, 3 pM donor probe, 2 pM acceptor probe, 2 µl DNA extract and PCR-grade water to a final volume of 20 µl. All temperature transition rates were 20 °C s–1. Reaction conditions were 95 °C for 0 s, followed by 50 cycles of heating to 95 °C for 0 s, 52 °C for 2 s and 72 °C for 10 s. Melting curve analysis was carried out at 95 °C for 0 s, 43 °C for 5 s and 95 °C for 0 s at a transition rate of 0.2 °C s–1. Accumulation of specific PCR product was detected by measuring fluorescence in real time and analysed with LightCycler software. The amplicons were also subjected to agarose gel electrophoresis.

Sequencing of bexA amplicons.

Amplicons were purified using the QIAquick PCR Purification kit (Qiagen), according to manufacturer's instructions. The reaction mixture, comprising 1 µl Thermo Sequenase DYEnamic Direct Cycle Sequencing kit (Amersham Pharmacia Biotech), 1 pmol Cy5-labelled forward primer bexAF, 0.5 pmol Cy5.5-labelled reverse primer bexAR and 3 µl purified DNA, was processed in a Gene Amp PCR System 9700 thermal cycler (Applied Biosystems), using the following conditions: 94 °C for 5 min, followed by 25 cycles of 94 °C for 30 s, 52 °C for 30 s and 70 °C for 60 s. Sequencing was carried out on a Long Read Tower (Visible Genetics) under standard conditions and analysed with OpenGene System software (Visible Genetics).


    RESULTS AND DISCUSSION
 TOP
 INTRODUCTION
 METHODS
 RESULTS AND DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
On melting-curve analysis, the bexA-specific PCR amplicon produced a melting temperature of 62.5 °C. All 12 capsulate H. influenzae isolates produced PCR products of 343 bp as shown by agarose gel electrophoresis, but the characteristic melting curve was seen only with isolates of H. influenzae types a to d (Fig. 1). To investigate this, the bexA amplicons of all 12 capsulate H. influenzae strains were sequenced.



View larger version (15K):
[in this window]
[in a new window]
 
Fig. 1. Melting curves for bexA PCR amplicons, using bexAabcd probes. A, H. influenzae types a to d; B, H. influenzae types e and f, NC H. influenzae and negative controls.

 

Comparison of bexA sequences with the control H. influenzae type b (HIB) strain (NCTC 8467T) showed a similarity of 99.0–100 % for the eight tested strains of types a to d, but this was lower at 86.1–86.7 % for the four strains of HIE and HIF (sequence alignment data available as supplementary data in JMM Online). The two HIE strains had identical sequences, as did the two HIF strains. No capsulate H. influenzae strain showed nucleotide differences within the primer binding sites. However, each strain of HIE and HIF showed nine base pair changes within the probe binding sites (Fig. 2). This explains why all capsulate strains produced an amplicon of the correct 343 bp size with agarose gel electrophoresis; however, the probes failed to produce detectable melting curves with bexA products of HIE and HIF due to sequence variation.



View larger version (7K):
[in this window]
[in a new window]
 
Fig. 2. Alignment of part of the bexA gene sequence of HIB, HIE and HIF, showing differences within the hybridization probe binding sites (underlined).

 

With this in mind, a new set of probes was designed for HIE and HIF: bexAefD (5'-GAAAAGCGCAAAGACCGTTCC-fluorescein-3') and bexAefA (5'-LC Red 640-TTATTTT GGTTTCACACAGTCCA-phosphate-3') and tested on all isolates. Only HIE and HIF produced melting curves, with melting temperatures of 54 °C and 49 °C, respectively (Fig. 3).



View larger version (12K):
[in this window]
[in a new window]
 
Fig. 3. Melting curves for bexA PCR amplicons, using bexAef probes. HIE, H. influenzae type e; HIF, H. influenzae type f; A, H. influenzae types a to d, NC H. influenzae and negative controls.

 

Earlier conventional PCR studies successfully detected bexA in capsulate H. influenzae of all six types, although less-specific gel-based systems were used to confirm the product (Falla et al., 1994; Gonin et al., 2000; van Ketel et al., 1990). Only one other study has used real-time PCR to detect H. influenzae and attributed the failure to detect bexA from types a, d, e and f to sequence variation, but did not confirm this with sequencing (Corless et al., 2001). Our findings indicate that the HIE and HIF strains used in this study had sufficient bexA sequence variation compared with types a to d to preclude detection of all six serotypes using a single set of hybridization probes.

There are few data comparing bexA sequences among different capsule types. One study applied a 50 bp bexA probe to EcoRI-digested DNA from capsulate H. influenzae strains and found that types a, c and d produced identical fragments, while bound fragments for types e and f were of a different size (Kroll et al., 1988). Genetic analysis of HIF has shown 89–94 % similarity with HIB in region I of the cap locus, where bexA is located (Satola et al., 2003). Another study found as much as 16.5 % nucleotide difference between bexA sequences of two genetically divergent HIB strains (Kroll et al., 1990).

In this study, sequence variation within the bexA target region for HIE and HIF was suspected only because gel electrophoresis showed a product of the correct size, despite failure to produce a melting curve. This has implications for the surveillance of H. influenzae disease in this era of HIB vaccination, particularly if a highly specific method such as real-time PCR is used to type strains. Any capsulate H. influenzae strain with significant bexA sequence variation may be undetected and misclassified as NC. As the proportion of disease caused by NC types e and f strains has increased (Campos et al., 2004; Slack et al., 1998; Urwin et al., 1996), it is crucial that all capsule types are accurately identified.


    ACKNOWLEDGEMENTS
 TOP
 INTRODUCTION
 METHODS
 RESULTS AND DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
We thank Dr Mary Slack and Suzanne Stringer of the Health Protection Agency Haemophilus Reference Unit, Oxford, UK, for providing the bacterial isolates and technical advice.


    REFERENCES
 TOP
 INTRODUCTION
 METHODS
 RESULTS AND DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 

  • Campos, J., Hernando, M., Román, F., Pèrez-Vázquez, M., Aracil, B., Oteo, J., Lázaro, E., de Abajo, F. & the Group of Invasive Haemophilus influenzae Infections of the Autonomous Community of Madrid, Spain (2004). Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H.influenzae type b. J Clin Microbiol 42, 524–529.[Abstract/Free Full Text]

  • Corless, C. E., Guiver, M., Borrow, R., Edwards-Jones, V., Fox, A. J. & Kaczmarski, E. B. (2001). Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol 39, 1553–1558.[Abstract/Free Full Text]

  • Falla, T. J., Crook, D. W. M., Brophy, L. N., Maskell, D., Kroll, J. S. & Moxon, E. R. (1994). PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol 32, 2382–2386.[Abstract/Free Full Text]

  • Gonin, P., Lorange, M. & Delage, G. (2000). Performance of a multiplex PCR for the determination of Haemophilus influenzae capsular types in the clinical microbiology laboratory. Diagn Microbiol Infect Dis 37, 1–4.[CrossRef][Medline]

  • Kroll, J. S., Hopkins, I. & Moxon, E. R. (1988). Capsule loss in Haemophilus influenzae type b occurs by recombination-mediated disruption of a gene essential for polysaccharide export. Cell 53, 347–356.[CrossRef][Medline]

  • Kroll, J. S., Zamze, S., Loynds, B. & Moxon, E. R. (1989). Common organization of chromosomal loci for production of different capsular polysaccharides in Haemophilus influenzae. J Bacteriol 171, 3343–3347.[Abstract/Free Full Text]

  • Kroll, J. S., Loynds, B. M. & Moxon, E. R. (1990). The bex locus in encapsulated Haemophilus influenzae: a chromosomal region involved in capsule polysaccharide export. Mol Microbiol 4, 1853–1862.[Medline]

  • Satola, S. W., Schirmer, P. L. & Farley, M. M. (2003). Genetic analysis of the capsule locus of Haemophilus influenzae serotype f. Infect Immun 71, 7202–7207.[Abstract/Free Full Text]

  • Slack, M. P. E., Azzopardi, H. J., Hargeaves, R. M. & Ramsay, M. E. (1998). Enhanced surveillance of invasive Haemophilus influenzae disease in England, 1990 to 1996: impact of conjugate vaccines. Pediatr Infect Dis J 17, S204–S207.[CrossRef][Medline]

  • Urwin, G., Krohn, J. A., Deaver-Robinson, K., Wenger, J. D., Farley, M. M. & the Haemophilus influenzae Study Group (1996). Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiologic characteristics in the H.influenzae serotype b vaccine era. Clin Infect Dis 22, 1069–1076.[Medline]

  • van Ketel, R. J., de Wever, B. & van Alphen, L. (1990). Detection of Haemophilus influenzae in cerebrospinal fluids by polymerase chain reaction DNA amplification. J Med Microbiol 33, 271–276.[Abstract/Free Full Text]




    This article has been cited by other articles:


    Home page
    J. Clin. Microbiol.Home page
    Y. Maaroufi, J.-M. De Bruyne, C. Heymans, and F. Crokaert
    Real-Time PCR for Determining Capsular Serotypes of Haemophilus influenzae
    J. Clin. Microbiol., July 1, 2007; 45(7): 2305 - 2308.
    [Abstract] [Full Text] [PDF]


    Home page
    J. Clin. Microbiol.Home page
    J. Zhou, D. K. S. Law, M. L. Sill, and R. S. W. Tsang
    Nucleotide Sequence Diversity of the bexA Gene in Serotypeable Haemophilus influenzae Strains Recovered from Invasive Disease Patients in Canada
    J. Clin. Microbiol., June 1, 2007; 45(6): 1996 - 1999.
    [Abstract] [Full Text] [PDF]


    This Article
    Right arrow Abstract Freely available
    Right arrow Full Text (PDF)
    Right arrow Index
    Right arrow Alert me when this article is cited
    Right arrow Alert me if a correction is posted
    Right arrow Citation Map
    Services
    Right arrow Email this article to a friend
    Right arrow Similar articles in this journal
    Right arrow Similar articles in PubMed
    Right arrow Alert me to new issues of the journal
    Right arrow Download to citation manager
    Right arrow reprints & permissions
    Citing Articles
    Right arrow Citing Articles via HighWire
    Right arrow Citing Articles via CrossRef
    Right arrow Citing Articles via Google Scholar
    Google Scholar
    Right arrow Articles by Sam, I.-C
    Right arrow Articles by Smith, M
    Right arrow Search for Related Content
    PubMed
    Right arrow PubMed Citation
    Right arrow Articles by Sam, I.-C
    Right arrow Articles by Smith, M
    Agricola
    Right arrow Articles by Sam, I.-C
    Right arrow Articles by Smith, M


    HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
    INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS